Bionime Corp

Bionime Corp

4737 · TW · Healthcare / Medical Instruments & Supplies

56.10TWD+0.80 (+1.45%)

Price History

Full chart

Market Stats

Previous Close55.30
Open55.90
Day Range55.90 – 56.80
52-Week Range49.75 – 72.90
Volume25.01K
Market Cap4.35B
P/E (TTM)0.00
Forward P/E0.00
EPS-4.02
Dividend Yield0.00%
Beta-0.12
50-Day Avg57.10
200-Day Avg58.19

About

Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Belarus, Algeria, the United Arab Emirates, Egypt, and internationally. The company manufactures and sells blood glucose meters and test strips to medical equipment companies, pharmacies, and hospitals, as well as offering blood glucose monitoring devices and systems under the RIGHTEST brand; a continuous glucose monitoring system under the iFree CGM brand; and medical blood glucose management systems. It is also involved in the provision of biotechnology services; drug testing; examination of pharmaceutical products; and the sale of precision instruments. The company also provides wholesale medical devices, biotechnology services, pharmaceutical testing, and wholesale of precision instruments. Bionime Corporation was incorporated in 2003 and is based in Taichung, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Chun-Mu Huang
  • Employees0
  • HeadquartersNo. 100, Daqing Street, Taichung, Taiwan, 40242, Taiwan
  • Websitehttps://www.bionime.com

Leadership

  • Mr. Chun-Mu HuangFounder, Chairman & GM
  • Sherry HuangManager of Human Resources Department & Financial Officer
  • Mr. Yu-Jen HsiuAssistant General Manager of Operation Division
  • Ms. Ya-Wen ChenAccounting Supervisor
  • Ms. Hui-Zhen ChenAssistant GM of Administration Division & Corporate Governance Officer
  • Zhen Teng XuVice President of Research and Development
  • Mr. Cheng-Hong ShiAssistant General Manager of Sales Division
  • Mr. Ming-Lun ZhangAssistant General Manager of Marketing Planning Division

Financials

Income Statement

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue937.75M1.21B1.48B1.44B1.56B1.52B1.61B1.74B1.82B2.01B2.17B1.67B1.85B2.21B1.76B1.93B1.84B
Growth (%)-+29.22%+21.85%-2.81%+8.77%-2.32%+5.58%+8.11%+4.59%+10.27%+8.26%-23.21%+10.87%+19.50%-20.58%+10.15%-4.92%
Cost of Revenue483.47M613.96M765.31M808.81M933.11M930.05M908.43M969.82M1.02B1.09B1.22B919.46M1.07B1.21B1.04B1.17B1.21B
Gross Profit454.28M597.79M711.23M626.21M627.79M594.62M701.29M770.49M795.77M917.00M948.42M749.13M783.13M1.00B715.65M768.38M627.81M
Gross Margin48.44%49.33%48.17%43.64%40.22%39.00%43.57%44.27%43.72%45.68%43.65%44.90%42.33%45.42%40.76%39.74%34.15%
Operating Expense304.13M397.46M517.65M555.35M482.92M445.31M511.51M512.09M547.36M677.70M771.88M673.18M710.06M857.41M728.99M897.43M825.17M
Operating Income150.15M200.33M193.58M70.86M144.88M149.31M189.78M258.40M248.42M239.30M176.53M75.95M73.07M146.72M-13.34M-129.05M-197.36M
Operating Margin16.01%16.53%13.11%4.94%9.28%9.79%11.79%14.85%13.65%11.92%8.12%4.55%3.95%6.64%-0.76%-6.67%-10.73%
EBITDA185.71M205.42M292.81M177.15M252.21M299.06M334.32M394.33M357.79M342.34M330.84M216.15M248.29M270.36M179.78M59.28M-15.08M
EBITDA Margin19.80%16.95%19.83%12.34%16.16%19.61%20.77%22.66%19.66%17.06%15.23%12.95%13.42%12.23%10.24%3.07%-0.82%
Net Income135.24M136.05M179.11M34.15M89.93M54.31M98.79M178.79M149.61M128.03M106.26M62.43M87.41M91.03M6.21M-127.22M-180.28M
Net Income Margin14.42%11.23%12.13%2.38%5.76%3.56%6.14%10.27%8.22%6.38%4.89%3.74%4.73%4.12%0.35%-6.58%-9.81%
R&D46.02M63.39M100.11M100.04M101.20M92.00M117.78M140.38M159.96M201.19M255.12M247.88M187.86M201.98M242.34M322.33M354.75M
R&D as % of Total Revenue4.91%5.23%6.78%6.97%6.48%6.03%7.32%8.07%8.79%10.02%11.74%14.86%10.16%9.14%13.80%16.67%19.29%
Interest Expense5.00K134.00K5.47M13.73M22.79M65.63M57.74M22.39M22.54M29.05M31.79M21.55M19.05M30.65M48.23M62.19M64.90M
Interest Expense % of Total Revenue0.00%0.01%0.37%0.96%1.46%4.30%3.59%1.29%1.24%1.45%1.46%1.29%1.03%1.39%2.75%3.22%3.53%

Balance Sheet

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets892.09M1.29B2.85B3.63B4.52B4.67B4.57B4.65B4.37B4.59B4.40B4.49B4.56B4.98B5.30B5.78B5.70B
Total Liabilities251.19M270.64M1.77B2.63B3.45B3.32B2.03B2.06B2.30B2.60B2.36B2.41B2.49B2.90B3.31B3.89B3.95B
Total Equity640.89M1.02B1.09B1.00B1.07B1.35B2.54B2.59B2.08B1.99B2.04B2.07B2.07B2.07B1.99B1.88B1.75B
Cash347.61M492.05M422.19M231.92M662.27M865.51M816.27M588.88M174.35M433.63M359.56M343.25M253.09M214.49M391.82M321.23M423.12M
Total Debt101.86M110.75M1.55B2.49B3.18B2.88B1.70B1.56B1.86B2.12B1.85B2.01B2.03B2.27B2.82B3.17B3.06B
Net Debt-245.74M-381.30M1.13B2.25B2.52B2.02B882.26M974.81M1.68B1.69B1.49B1.66B1.78B2.06B2.43B2.85B2.64B

Cash Flow

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow207.56M13.66M216.93M23.57M128.98M359.84M200.37M457.84M29.60M121.90M405.56M217.56M269.72M142.29M203.44M19.53M494.80M
Investing Cash Flow-29.29M-106.76M-1.57B-1.05B-474.49M-55.57M-159.45M-414.95M-65.73M110.40M-129.09M-330.77M-288.07M-312.26M-435.26M-336.90M-286.07M
Financing Cash Flow-6.14M248.37M1.27B837.93M768.95M-107.81M-93.85M-261.38M-361.80M20.55M-338.02M96.33M-69.30M113.64M420.40M217.30M-108.53M
Capital Expenditure46.12M105.46M1.56B1.01B476.56M56.95M137.33M36.80M123.06M168.77M138.07M296.39M284.57M312.92M441.40M332.82M288.39M
Free Cash Flow161.44M-91.80M-1.34B-984.94M-347.58M302.90M63.03M421.04M-93.46M-46.87M267.48M-78.84M-14.85M-170.63M-237.95M-313.29M206.41M
Dividends Paid8.37M115.95M119.86M158.21M35.16M78.22M48.36M126.89M241.10M237.83M114.89M118.66M124.28M121.20M127.69M122.00M-
FCF to OCF77.78%-671.95%-618.28%-4177.90%-269.48%84.17%31.46%91.96%-315.75%-38.45%65.95%-36.24%-5.50%-119.91%-116.96%-1604.15%41.72%
Dividend Paid to FCF5.18%-126.32%-8.94%-16.06%-10.11%25.83%76.72%30.14%-257.97%-507.45%42.95%-150.51%-837.10%-71.03%-53.66%-38.94%-

Earnings

Report DateSep 1, 2010Dec 1, 2010Mar 2, 2011Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012Apr 30, 2012Aug 29, 2012Oct 30, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 12, 2014Nov 14, 2014Mar 29, 2015May 13, 2015Aug 6, 2015Nov 11, 2015Mar 10, 2016May 12, 2016Aug 11, 2016Nov 10, 2016Mar 15, 2017May 10, 2017Aug 9, 2017Nov 8, 2017Mar 20, 2018May 14, 2018Aug 12, 2018Nov 8, 2018Mar 13, 2019May 10, 2019Aug 12, 2019Nov 4, 2019Mar 16, 2020Jun 3, 2020Sep 2, 2020Dec 2, 2020Mar 3, 2021May 12, 2021Aug 11, 2021Dec 1, 2021Mar 2, 2022Jun 1, 2022Aug 31, 2022Nov 10, 2022Mar 15, 2023May 10, 2023May 10, 2024Aug 14, 2024
EPS Estimate-------0.58-0.84-------0.330.36-0.360.720.750.200.49-0.650.29---0.74-1.260.95-0.550.390.88----0.04-0.11----0.570.55--0.010.15
EPS Actual1.381.020.920.900.900.891.300.020.030.500.170.460.710.700.140.060.050.220.790.390.220.530.620.200.570.851.120.370.490.810.800.220.460.410.950.120.600.090.85-0.14-0.260.670.750.180.200.500.530.230.640.150.41-0.09-0.07-0.54
Surprise--------96.55%--40.48%--------33.33%119.44%--38.89%-26.39%-17.33%0.00%16.33%-72.31%27.59%----70.27%--67.46%0.00%-9.09%-76.92%-3.41%----350.00%281.82%-----73.68%-25.45%--600.00%-460.00%
Timing-------Pre-market-After-hours------Pre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market----Pre-marketAfter-hours----Pre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap4.35B
Enterprise Value6.69B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales2.53
Price / Book2.13
EPS-4.02
Book Value27.17
Revenue (TTM)1.72B
Gross Profit (TTM)576.20M
EBITDA-153.94M
Profit Margin-16.67%
Operating Margin-12.30%
Return on Equity-14.17%
Return on Assets-3.39%
Shares Outstanding77.29M
Shares Float45.92M
Beta-0.12
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
0.38Jul 24, 2023
20221×
1.25Jul 21, 2022
20211×
0.86Jul 26, 2021
20201×
1.50Jul 23, 2020
20191×
2.00Aug 1, 2019
20181×
4.14Jul 9, 2018
20171×
2.77Jul 10, 2017
20161×
1.40Jul 28, 2016
20151×
0.94Aug 31, 2015
20141×
1.75Sep 4, 2014
20131×
0.79Aug 22, 2013
20121×
3.54Jul 13, 2012
20111×
2.95Jul 22, 2011
20101×
2.86Jul 27, 2010

Stock Splits

  • Nov 20, 2014662:651
  • Jul 22, 201111:10